Sanaria Inc.

29 clinical trials · Sponsor

Record	Firm	Date
Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso (NCT07730177)	Sanaria Inc.	2027-03-01
PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in Mali (NCT07675785)	Sanaria Inc.	2026-07-20
Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults (NCT07385287)	Sanaria Inc.	2026-05-04
Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults (NCT06862453)	Sanaria Inc.	2026-03-12
Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso (NCT06652737)	Sanaria Inc.	2025-03-04
A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI (NCT05604521)	Sanaria Inc.	2022-12-06
Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria (NCT03503058)	Sanaria Inc.	2022-05-07
PfSPZ Vaccine Trial in Malian Children (NCT04940130)	Sanaria Inc.	2022-04-01
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults (NCT04966871)	Sanaria Inc.	2021-09-27
Regimen Optimization Trial of PfSPZ Vaccine in Equatorial Guinea (NCT03590340)	Sanaria Inc.	2018-07-30
Safety, Tolerability and Protective Efficacy of PfSPZ Vaccine in Gabonese Children (NCT03521973)	Sanaria Inc.	2018-06-14
Study to Evaluate Safety, Immunogenicity and Efficacy of PfSPZ Vaccine in HIV Negative and HIV Positive Tanzanian Adults (NCT03420053)	Sanaria Inc.	2018-02-07

Every clearance here is in the API, with alerts when new ones post.